June 17, 2022
Article
This past week has been extremely busy in infectious disease with a lot of vaccine news that could impact young children. In addition, GSK reported on its phase 3 study on its RSV vaccine for seniors.
June 15, 2022
The FDA VRBPAC votes to recommend mRNA vaccines in youngest children; WHO moves to rename monkeypox; Anthony Fauci is diagnosed with COVID-19; and Pfizer stops recruiting for a Paxlovid trial.
June 07, 2022
GSK’s Priorix MMR vaccine received the federal agency’s approval which was based from data of 6 clinical trials evaluating its safety.
June 02, 2022
The White House coronavirus response coordinator said vaccines for children under 5 could potentially begin on June 21.
May 16, 2022
This is the first test authorized for all 3 viruses and is over the counter.
April 08, 2022
Here is a rundown of the most popular stories we covered this past week.
Monkeypox Symptoms in London Patients Differ from Prior Outbreaks
How COVID-19 Infiltrates and Inflames the Heart
Top 5 Infectious Disease Stories of the Week: July 1, 2022
Communities With More Racial Prejudice Have Worse Health Outcomes